When Naturals had grown from a niche protein-bar business into a healthy-snacking brand, its founder faced the question that changes many profitable companies: how to fund the next stage while ensuring those who built it could share in the success.

In this episode of The War Room, he traces the consumer insight that broadened the brand’s market, the capital pressure behind the decision to take outside investment, and the decision to build employee ownership into the company before bringing in Rabo. After revenue rose from roughly ₹30 crore to ₹150 crore and the fund needed an exit, he had to decide whether a new investor or a strategic buyer could take the brand towards ₹1,000 crore.

He explains why Zydus Wellness was selected: not simply for scale, but for a plan to preserve independence, support existing distributors and suppliers, and protect the brand’s character. At the heart of the deal is a hard-edged conviction about shared upside: an additional ₹5 crore for employee distribution and payouts structured above the investor per-share price. The conversation closes on stewardship, succession, and Smita’s role in shaping the taste and design behind the brands.

How does a fledgling Stevia experiment morph into India’s largest home-grown protein-bar brand and land a blockbuster strategic buy-out? In this War Room episode, founder Vijay shares the decisions that powered Natural’s Max Protein from a kitchen-table idea to a ₹150-crore healthy-snacking powerhouse. He opens with the near-empty bank balance that forced a pivot from sweetener sachets to high-protein bars, then unpacks why he turned down early venture money until repeat customers proved the category. Listeners hear the consumer insight that moved the bar from gym racks to supermarket snack aisles, and the radical ESOP plan that handed equity to everyone from vice-presidents to office boys. Finally, Vijay walks through the four competing term sheets that appeared in one frantic fortnight and explains why a 100 % sale to Zydus Wellness – at a higher per-share price for employees than investors – felt like the right next chapter. A masterclass in disciplined scaling, culture-first ownership and timing the perfect exit.

Vijay Uttarwar began selling a protein bar to gym rats from a single Mumbai storefront. Fifteen years later, Max Protein sits in every Indian supermarket aisle and has just been acquired in a ₹450-crore cash deal by pharma giant Zydus Wellness. In this episode of The War Room, the veteran founder unpacks the checkpoints that turned a niche supplement into a ₹150-crore healthy-snacking brand—and why he waited until revenue hit ₹30 crore before taking a rupee of outside money.

Listeners hear the inside math behind a 5× growth spurt fuelled by Rabo’s agri-fund, the near-miss emotions of negotiating four simultaneous term sheets during a funding winter, and the radical decision to grant ESOPs to every employee—from vice-presidents to office boys. Vijay explains how he convinced Zydus to preserve jobs, funnel ₹5 crore extra to staff and suppliers, and let his wife Smita keep steering flavour innovation.

Whether you’re a consumer-brand operator, early employee, or investor hunting fair-return stories, this conversation offers a masterclass on aligning mission, money and legacy.

The War Room tracks the 20-year journey of Right Bite Max Protein’s founder, who turned a home-grown protein bar into a ₹150-crore healthy-snacking force—and then sold 100 percent of it to Zydus Wellness. Listeners hear why he refused venture capital for years, the consumer insight that shifted the bar from gym supplement to everyday snack, and how a values-aligned cheque from Rabo turbo-charged revenue five-fold. The conversation peels back the mechanics of a broad ESOP that gave 250 employees real skin in the game, the gruelling beauty parade that produced four competing term sheets, and the stakeholder-first negotiations that guaranteed no layoffs and a ₹5-crore employee bonus pool. Along the way, the veteran founder wrestles with turning 60, handing the reins to a strategic giant, and crediting his wife Smita for every flavour that flew off the shelf. It’s a masterclass in timing your raise, sharing the upside, and exiting on your own terms.

The War Room sits down with RiteBite Max Protein founder Vijay Kandpal to unpack a journey that began with a rented apartment and finished with a headline-grabbing strategic sale. Kandpal recalls scraping together personal savings and rental income to push revenues past ₹30 crore, keeping less money in his Mumbai bank than in the US account he left behind. A chance insight—customers were snacking, not ‘supplementing’—unlocked the far larger healthy-snacking market and convinced him to finally accept venture capital. With Rabo’s funds he widened distribution, grew five-fold to ₹150 crore and, unusually for Indian FMCG, granted stock options to every employee: office boys, factory operators and VPs alike. When both he and his investors searched for an exit, Kandpal chose Zydus Wellness, structuring a 100 percent buyout that preserves jobs and sets aside an extra ₹5 crore so more than 250 staff can cash life-changing cheques. It’s a masterclass in capital discipline, brand positioning and people-first deal-making—told by the man who lived every trade-off.

Fifteen years ago, former fitness enthusiast Vijay mixed small batches of protein bars in a cramped Mumbai kitchen and sold them door-to-door. Max Protein scraped its way to ₹25 crore in sales, but cash was always a heartbeat away from zero. In this episode of The War Room, he retraces every inflection point that turned those lean days into a ₹150 crore powerhouse and, ultimately, a full acquisition by Zydus Wellness.

Listeners follow a step-by-step growth playbook: reframing the bar from niche supplement to everyday snack; convincing Rabo India Agri Fund to bankroll national marketing; issuing one of India’s earliest FMCG-wide ESOPs so even receptionists owned shares; and navigating a bruising sale process during a funding winter. Vijay breaks down why Zydus’s promise of an independent subsidiary—and zero layoffs—beat richer bids, and how an extra ₹5 crore pool let 250 employees earn more per share than his VC backer.

It’s a masterclass in scaling consumer brands while spreading the spoils of victory.

Vijay Uttarwar spent years tinkering with Stevia-sweetened products before discovering that Indian consumers craved convenient protein, not another sugar substitute. In this episode of The War Room he traces how that moment of insight spawned Max Protein, a brand that would grow five-fold and eventually fetch a ₹150-crore cheque from pharma heavyweight Zydus Wellness.

The conversation walks through every strategic fork in the road: bootstrapping with family savings, resisting flashy venture capital until Rabo India’s agri-fund offered smart money for marketing, talent and plant upgrades; handing out all-staff ESOPs long before it was fashionable; and staring down a make-or-sell dilemma as revenues hit nine figures while his investors’ fund life ticked down.

Listeners hear the inside baseball of an acquisition completed during a funding freeze—why Zydus beat three other suitors, how the deal ring-fenced jobs, distributors and even paid employees more per share than the exiting fund. Finally, at 60, Vijay reflects on stepping into an advisory seat, the creative genius of his wife Smita, and the social projects he hopes will define his next 20 years.

Vijay Uttamchandani began in a Mumbai garage with a Stevia-sweetened snack and a conviction that marketing rupees must pay for themselves. A decade later his Right Bite Max Protein line sits inside Zydus Wellness after an all-cash, ₹150-crore revenue run and one of the widest employee pay-outs the Indian consumer sector has seen. In this episode of The War Room, he walks host Rohit through every fork in the road: surviving six years without venture money, persuading Rabo’s agri-fund to back a “healthy snack”, writing ESOP cheques for office staff and shop promoters, and negotiating a sale that protects jobs and distributor relationships while rewarding workers with a bigger per-share price than investors. Along the way he reveals the maths behind refusing early term sheets, the moment a 5× growth spurt forced his hand, and why turning 60 has him plotting twenty purpose-driven years ahead. A masterclass in capital discipline, inclusive wealth, and knowing when to let go.